Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Clinical applications of 68Ga-DOTANOC in neuroendocrine tumours.

Lopci E, Nanni C, Rampin L, Rubello D, Fanti S.

Minerva Endocrinol. 2008 Sep;33(3):277-81. Review.

PMID:
18846030
2.

Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.

Wild D, Bomanji JB, Benkert P, Maecke H, Ell PJ, Reubi JC, Caplin ME.

J Nucl Med. 2013 Mar;54(3):364-72. doi: 10.2967/jnumed.112.111724.

3.

68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.

Ambrosini V, Campana D, Bodei L, Nanni C, Castellucci P, Allegri V, Montini GC, Tomassetti P, Paganelli G, Fanti S.

J Nucl Med. 2010 May;51(5):669-73. doi: 10.2967/jnumed.109.071712.

4.

PET imaging in neuroendocrine tumors: current status and future prospects.

Basu S, Kumar R, Rubello D, Fanti S, Alavi A.

Minerva Endocrinol. 2008 Sep;33(3):257-75. Review.

PMID:
18846029
5.
6.

Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors.

Kaemmerer D, Peter L, Lupp A, Schulz S, Sänger J, Baum RP, Prasad V, Hommann M.

Int J Clin Exp Pathol. 2012;5(3):187-94.

7.

Gallium-68 PET: a new frontier in receptor cancer imaging.

Al-Nahhas A, Win Z, Szyszko T, Singh A, Nanni C, Fanti S, Rubello D.

Anticancer Res. 2007 Nov-Dec;27(6B):4087-94. Review.

8.

Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy.

Hicks RJ.

Cancer Imaging. 2010 Oct 4;10 Spec no A:S83-91. doi: 10.1102/1470-7330.2010.9007. Review.

9.

[Diagnosis, staging and follow-up of neuroendocrine tumors: role of somatostatin receptors scintigraphy].

Lebtahi R.

Ann Pathol. 2011 Nov;31(5 Suppl):S83-4. doi: 10.1016/j.annpat.2011.08.017. French. No abstract available.

PMID:
22054471
10.

Somatostatin receptor expressing bilateral ovarian metastases detected by (68)Ga DOTANOC PET/CT.

Arora S, Soundararajan R, Joshi P, Kumar R, Bal C.

Clin Nucl Med. 2015 Jun;40(6):496-8. doi: 10.1097/RLU.0000000000000646.

PMID:
25546200
11.

The diagnostic role of 68Ga-DOTATATE PET/CT in the detection of neuroendocrine tumours.

Łapińska G, Bryszewska M, Fijołek-Warszewska A, Kozłowicz-Gudzińska I, Ochman P, Sackiewicz-Słaby A.

Nucl Med Rev Cent East Eur. 2011;14(1):16-20.

12.

68Ga DOTANOC PET/CT in primary neuroendocrine tumor of the breast.

Mukherjee A, Karunanithi S, Singla S, Bal C, Kumar R.

Clin Nucl Med. 2014 Apr;39(4):396-8. doi: 10.1097/RLU.0000000000000390.

PMID:
24566407
13.
14.

⁶⁸Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin.

Naswa N, Sharma P, Kumar A, Soundararajan R, Kumar R, Malhotra A, Ammini AC, Bal C.

Clin Nucl Med. 2012 Mar;37(3):245-51. doi: 10.1097/RLU.0b013e31823ea730.

PMID:
22310250
15.

[68Ga-DOTA-PET for neuroendocrine tumours].

Loimaala A, Mäenpää H, Lipponen T, Schildt J, Kämäräinen EL, Karhumäki L, Ahonen A.

Duodecim. 2014;130(19):1931-8. Finnish.

PMID:
25558614
16.

⁶⁸Ga-labelled peptides for diagnosis of gastroenteropancreatic NET.

Ambrosini V, Campana D, Tomassetti P, Fanti S.

Eur J Nucl Med Mol Imaging. 2012 Feb;39 Suppl 1:S52-60. doi: 10.1007/s00259-011-1989-4. Review.

PMID:
22388622
17.

Predictive value of 68Ga-DOTANOC PET/CT in patients with suspicion of neuroendocrine tumors: is its routine use justified?

Sharma P, Arora S, Mukherjee A, Pal S, Sahni P, Garg P, Khadgawat R, Thulkar S, Bal C, Kumar R.

Clin Nucl Med. 2014 Jan;39(1):37-43. doi: 10.1097/RLU.0000000000000257.

PMID:
24152621
18.

PET tracers for somatostatin receptor imaging of neuroendocrine tumors: current status and review of the literature.

Johnbeck CB, Knigge U, Kjær A.

Future Oncol. 2014 Nov;10(14):2259-77. doi: 10.2217/fon.14.139. Review.

19.

Functional imaging of neuroendocrine tumours with PET.

Mottaghy FM, Reske SN.

Pituitary. 2006;9(3):237-42. Review.

PMID:
17036194
20.

An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.

Stelter L, Amthauer H, Rexin A, Pinkernelle J, Schulz P, Michel R, Denecke T, Stiepani H, Hamm B, Wiedenmann B, Scholz A.

Neuroendocrinology. 2008;87(4):233-42.

PMID:
18025811
Items per page

Supplemental Content

Support Center